{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:56:22Z","timestamp":1782932182180,"version":"3.54.5"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Agence nationale de la recherche"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Lysosomal acid lipase deficiency (LAL-D) is an autosomal recessive disorder caused by mutations in the\n                      <jats:italic>LIPA<\/jats:italic>\n                      gene, which results in lipid accumulation leading to multi-organ failure. If left untreated, the severe form of LAL-D results in premature death within the first year of life due to failure to thrive and hepatic insufficiency. Weekly systemic injections of recombinant LAL protein, referred as enzyme replacement therapy, is the only available supportive treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      Here, we characterized a novel\n                      <jats:italic>Lipa<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      mouse model and developed a curative gene therapy treatment based on the in vivo administration of recombinant (r)AAV8 vector encoding the human\n                      <jats:italic>LIPA<\/jats:italic>\n                      transgene under the control of a hepatocyte-specific promoter.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Here we define the minimal rAAV8 dose required to rescue disease lethality and to correct cholesterol and triglyceride accumulation in multiple organs and blood. Finally, using liver transcriptomic and biochemical analysis, we show mitochondrial impairment in\n                      <jats:italic>Lipa<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      mice and its recovery by gene therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Overall, our in vivo gene therapy strategy achieves a stable long-term LAL expression sufficient to correct the disease phenotype in the\n                      <jats:italic>Lipa<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      mouse model and offers a new therapeutic option for LAL-D patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-025-00816-8","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T09:22:56Z","timestamp":1744363376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Rescue of lysosomal acid lipase deficiency in mice by rAAV8 liver gene transfer"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-9999","authenticated-orcid":false,"given":"Marine","family":"Laurent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Oustelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Cosette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Landini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristide","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-8336","authenticated-orcid":false,"given":"Guillaume","family":"Corre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-7799","authenticated-orcid":false,"given":"Nemanja","family":"Vujic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Brassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Van Wittenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-0210","authenticated-orcid":false,"given":"Giuseppe","family":"Ronzitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-7573","authenticated-orcid":false,"given":"Dagmar","family":"Kratky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4915-5823","authenticated-orcid":false,"given":"Consiglia","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1188-8856","authenticated-orcid":false,"given":"Mario","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"816_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jacl.2014.07.006","volume":"8","author":"WV Brown","year":"2014","unstructured":"Brown, W. V., Desnick, R. J. & Grabowski, G. A. JCL Roundtable: enzyme replacement therapy for lipid storage disorders. J. Clin. Lipidol. 8, 463\u2013472 (2014).","journal-title":"J. Clin. Lipidol."},{"key":"816_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/lipd.12325","volume":"57","author":"AA Aqul","year":"2022","unstructured":"Aqul, A. A. et al. Molecular markers of brain cholesterol homeostasis are unchanged despite a smaller brain mass in a mouse model of cholesteryl ester storage disease. Lipids 57, 3\u201316 (2022).","journal-title":"Lipids"},{"key":"816_CR3","doi-asserted-by":"crossref","unstructured":"Balwani, M. et al. Lysosomal acid lipase deficiency manifestations in children and adults: Baseline data from an international registry. Liver Int. n\/a (2023).","DOI":"10.1111\/liv.15620"},{"key":"816_CR4","doi-asserted-by":"publisher","first-page":"04","DOI":"10.1016\/j.jped.2021.03.003","volume":"98","author":"C da","year":"2022","unstructured":"da, C. et al. Lysosomal acid lipase deficiency in pediatric patients: a scoping review. J. Pediatr. (Rio J.) 98, 04\u201314 (2022).","journal-title":"J. Pediatr. (Rio J.)"},{"key":"816_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ymgme.2018.03.010","volume":"124","author":"DL Bernstein","year":"2018","unstructured":"Bernstein, D. L. et al. Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients. Mol. Genet. Metab. 124, 11\u201319 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"816_CR6","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","volume":"58","author":"DL Bernstein","year":"2013","unstructured":"Bernstein, D. L., H\u00fclkova, H., Bialer, M. G. & Desnick, R. J. Cholesteryl ester storage disease: Review of the findings in 135 reported patients with an underdiagnosed disease. J. Hepatol. 58, 1230\u20131243 (2013).","journal-title":"J. Hepatol."},{"key":"816_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/bmt.2008.273","volume":"43","author":"J Tolar","year":"2009","unstructured":"Tolar, J. et al. Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplant 43, 21 (2009).","journal-title":"Bone Marrow Transplant"},{"key":"816_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01849-7","volume":"16","author":"JE Potter","year":"2021","unstructured":"Potter, J. E. et al. Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease. Orphanet J. Rare Dis. 16, 235 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"816_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jhep.2021.10.026","volume":"76","author":"BK Burton","year":"2022","unstructured":"Burton, B. K., Feillet, F., Furuya, K. N., Marulkar, S. & Balwani, M. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study. J. Hepatol. 76, 577\u2013587 (2022).","journal-title":"J. Hepatol."},{"key":"816_CR10","doi-asserted-by":"crossref","unstructured":"Vijay, S. et al. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet J. Rare Dis. 16, 13 (2021).","DOI":"10.1186\/s13023-020-01577-4"},{"key":"816_CR11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1089\/104303402760128586","volume":"13","author":"H Du","year":"2002","unstructured":"Du, H., Heur, M., Witte, D. P., Ameis, D. & Grabowski, G. A. Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice. Hum. Gene Ther. 13, 1361\u20131372 (2002).","journal-title":"Hum. Gene Ther."},{"key":"816_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","volume":"102","author":"AM Davidoff","year":"2003","unstructured":"Davidoff, A. M., Ng, C. Y. C., Zhou, J., Spence, Y. & Nathwani, A. C. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood 102, 480\u2013488 (2003).","journal-title":"Blood"},{"key":"816_CR13","doi-asserted-by":"publisher","first-page":"12693","DOI":"10.3390\/ijms232012693","volume":"23","author":"M Piechnik","year":"2022","unstructured":"Piechnik, M. et al. Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy. Int. J. Mol. Sci. 23, 12693 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"816_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17552-3","volume":"11","author":"G Pavani","year":"2020","unstructured":"Pavani, G. et al. Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nat. Commun. 11, 3778 (2020).","journal-title":"Nat. Commun."},{"key":"816_CR15","doi-asserted-by":"publisher","first-page":"16049","DOI":"10.1038\/mtm.2016.49","volume":"3","author":"G Ronzitti","year":"2016","unstructured":"Ronzitti, G. et al. A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome. Mol. Ther. Methods Clin. Dev. 3, 16049 (2016).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"816_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2174\/156652310793797685","volume":"10","author":"E Ayuso","year":"2010","unstructured":"Ayuso, E., Mingozzi, F. & Bosch, F. Production, purification and characterization of adeno-associated vectors. Curr. Gene Ther. 10, 423\u2013436 (2010).","journal-title":"Curr. Gene Ther."},{"key":"816_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0166-0934(02)00138-6","volume":"106","author":"U-P Rohr","year":"2002","unstructured":"Rohr, U.-P. et al. Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J. Virol. Methods 106, 81\u201388 (2002).","journal-title":"J. Virol. Methods"},{"key":"816_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"816_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"816_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550 (2014).","journal-title":"Genome Biol"},{"key":"816_CR21","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. Camb. Mass 2, 100141 (2021).","journal-title":"Innov. Camb. Mass"},{"key":"816_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C5MB00663E","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu, G. & He, Q.-Y. ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization. Mol. Biosyst. 12, 477\u2013479 (2016).","journal-title":"Mol. Biosyst."},{"key":"816_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cpcb.116","volume":"89","author":"C Osto","year":"2020","unstructured":"Osto, C. et al. Measuring Mitochondrial Respiration in Previously Frozen Biological Samples. Curr. Protoc. Cell Biol. 89, e116 (2020).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"816_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.omtm.2018.12.011","volume":"12","author":"F Collaud","year":"2019","unstructured":"Collaud, F. et al. Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome. Mol. Ther. Methods Clin. Dev. 12, 157\u2013174 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"816_CR25","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa2214084","volume":"389","author":"L D\u2019Antiga","year":"2023","unstructured":"D\u2019Antiga, L. et al. Gene Therapy in Patients with the Crigler-Najjar Syndrome. N. Engl. J. Med. 389, 620\u2013631 (2023).","journal-title":"N. Engl. J. Med."},{"key":"816_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.omtm.2020.11.005","volume":"20","author":"G De Sabbata","year":"2021","unstructured":"De Sabbata, G. et al. Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector. Mol. Ther. - Methods Clin. Dev. 20, 169\u2013180 (2021).","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"816_CR27","doi-asserted-by":"publisher","first-page":"785698","DOI":"10.3389\/fgeed.2022.785698","volume":"4","author":"M Lisjak","year":"2022","unstructured":"Lisjak, M. et al. Promoterless Gene Targeting Approach Combined to CRISPR\/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice. Front. Genome Ed. 4, 785698 (2022).","journal-title":"Front. Genome Ed."},{"key":"816_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.omtm.2020.11.016","volume":"20","author":"X Shi","year":"2021","unstructured":"Shi, X. et al. Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients. Mol. Ther. - Methods Clin. Dev. 20, 287\u2013297 (2021).","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"816_CR29","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.2353\/ajpath.2010.091063","volume":"176","author":"P Qu","year":"2010","unstructured":"Qu, P. et al. Critical Roles of Lysosomal Acid Lipase in Myelopoiesis. Am. J. Pathol. 176, 2394\u20132404 (2010).","journal-title":"Am. J. Pathol."},{"key":"816_CR30","doi-asserted-by":"publisher","first-page":"40037","DOI":"10.18632\/oncotarget.16673","volume":"8","author":"S Schlager","year":"2017","unstructured":"Schlager, S. et al. Lysosomal lipid hydrolysis provides substrates for lipid mediator synthesis in murine macrophages. Oncotarget 8, 40037\u201340051 (2017).","journal-title":"Oncotarget"},{"key":"816_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molmed.2019.10.009","volume":"26","author":"CM Deus","year":"2020","unstructured":"Deus, C. M., Yambire, K. F., Oliveira, P. J. & Raimundo, N. Mitochondria-Lysosome Crosstalk: From Physiology to Neurodegeneration. Trends Mol. Med. 26, 71\u201388 (2020).","journal-title":"Trends Mol. Med."},{"key":"816_CR32","doi-asserted-by":"publisher","first-page":"e39598","DOI":"10.7554\/eLife.39598","volume":"8","author":"KF Yambire","year":"2019","unstructured":"Yambire, K. F. et al. Mitochondrial biogenesis is transcriptionally repressed in lysosomal lipid storage diseases. eLife 8, e39598 (2019).","journal-title":"eLife"},{"key":"816_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104941","volume":"25","author":"FW Chen","year":"2022","unstructured":"Chen, F. W. et al. Activation of mitochondrial TRAP1 stimulates mitochondria-lysosome crosstalk and correction of lysosomal dysfunction. iScience 25, 104941 (2022).","journal-title":"iScience"},{"key":"816_CR34","doi-asserted-by":"crossref","unstructured":"Akhmetshina, A. et al. Loss of lysosomal acid lipase results in mitochondrial dysfunction and fiber switch in skeletal muscles of mice. Mol. Metab. 79, 101869 (2023).","DOI":"10.1016\/j.molmet.2023.101869"},{"key":"816_CR35","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00125-016-3968-6","volume":"59","author":"B Radovi\u0107","year":"2016","unstructured":"Radovi\u0107, B. et al. Lysosomal acid lipase regulates VLDL synthesis and insulin sensitivity in mice. Diabetologia 59, 1743\u20131752 (2016).","journal-title":"Diabetologia"},{"key":"816_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12851","volume":"49","author":"S Licht-Mayer","year":"2023","unstructured":"Licht-Mayer, S. et al. Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis. Neuropathol. Appl. Neurobiol. 49, e12851 (2023).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"816_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10495-009-0408-9","volume":"15","author":"MK Tripathy","year":"2010","unstructured":"Tripathy, M. K. & Mitra, D. Differential modulation of mitochondrial OXPHOS system during HIV-1 induced T-cell apoptosis: up regulation of Complex-IV subunit COX-II and its possible implications. Apoptosis Int. J. Program. Cell Death 15, 28\u201340 (2010).","journal-title":"Apoptosis Int. J. Program. Cell Death"},{"key":"816_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/hum.2011.183","volume":"23","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, H., Bell, P., McMenamin, D. & Wilson, J. M. Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector. Hum. Gene Ther. 23, 533\u2013539 (2012).","journal-title":"Hum. Gene Ther."},{"key":"816_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/hep.24625","volume":"55","author":"M H\u00f6sel","year":"2012","unstructured":"H\u00f6sel, M. et al. Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors. Hepatology 55, 287\u2013297 (2012).","journal-title":"Hepatology"},{"key":"816_CR40","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1016\/j.ymthe.2022.07.005","volume":"30","author":"JSS Butterfield","year":"2022","unstructured":"Butterfield, J. S. S. et al. IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A mice. Mol. Ther. J. Am. Soc. Gene Ther. 30, 3552\u20133569 (2022).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"816_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ymgme.2011.06.002","volume":"104","author":"P Bell","year":"2011","unstructured":"Bell, P. et al. Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primates. Mol. Genet. Metab. 104, 395\u2013403 (2011).","journal-title":"Mol. Genet. Metab."},{"key":"816_CR42","doi-asserted-by":"crossref","unstructured":"Simoni, C. et al. Liver fibrosis negatively impacts in vivo gene transfer to murine hepatocytes. Nat. Commun. 16, 2119 (2025).","DOI":"10.1038\/s41467-025-57383-8"},{"key":"816_CR43","doi-asserted-by":"crossref","unstructured":"Bradi\u0107, I. et al. Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase. J. Lipid Res. 64, 100427 (2023).","DOI":"10.1016\/j.jlr.2023.100427"},{"key":"816_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-02134-3","volume":"16","author":"T Demaret","year":"2021","unstructured":"Demaret, T. et al. Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up. Orphanet J. Rare Dis. 16, 1\u20139 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"816_CR45","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1002\/ajmg.a.62923","volume":"188","author":"WB Hannah","year":"2022","unstructured":"Hannah, W. B. et al. Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly. Am. J. Med. Genet. A. 188, 3364\u20133368 (2022).","journal-title":"Am. J. Med. Genet. A."},{"key":"816_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nbt.1484","volume":"26","author":"J Wang","year":"2008","unstructured":"Wang, J. et al. Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment. Nat. Biotechnol. 26, 901\u2013908 (2008).","journal-title":"Nat. Biotechnol."},{"key":"816_CR47","doi-asserted-by":"publisher","first-page":"103728","DOI":"10.1016\/j.cellimm.2017.12.002","volume":"342","author":"GD Keeler","year":"2019","unstructured":"Keeler, G. D., Markusic, D. M. & Hoffman, B. E. Liver induced transgene tolerance with AAV vectors. Cell. Immunol. 342, 103728 (2019).","journal-title":"Cell. Immunol."},{"key":"816_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/156652309787909490","volume":"9","author":"PA LoDuca","year":"2009","unstructured":"LoDuca, P. A., Hoffman, B. E. & Herzog, R. W. Hepatic Gene Transfer as a Means of Tolerance Induction to Transgene Products. Curr. Gene Ther. 9, 104\u2013114 (2009).","journal-title":"Curr. Gene Ther."},{"key":"816_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.omtm.2016.12.010","volume":"4","author":"S Han","year":"2017","unstructured":"Han, S. et al. Low-dose liver-targeted gene therapy for Pompe disease enhances therapeutic efficacy of ERT via immune tolerance induction. Mol. Ther.-Methods Clin. Dev. 4, 126\u2013136 (2017).","journal-title":"Mol. Ther.-Methods Clin. Dev."},{"key":"816_CR50","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/emmm.201302859","volume":"5","author":"DM Markusic","year":"2013","unstructured":"Markusic, D. M. et al. Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies. EMBO Mol. Med. 5, 1698\u20131709 (2013).","journal-title":"EMBO Mol. Med."},{"key":"816_CR51","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1086\/522236","volume":"81","author":"B Sun","year":"2007","unstructured":"Sun, B. et al. Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. Am. J. Hum. Genet. 81, 1042\u20131049 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"816_CR52","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ymgme.2014.04.006","volume":"112","author":"Y Sun","year":"2014","unstructured":"Sun, Y. et al. Reversal of advanced disease in lysosomal acid lipase deficient mice: A model for lysosomal acid lipase deficiency disease. Mol. Genet. Metab. 112, 229\u2013241 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"816_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26744-4","volume":"12","author":"H Costa-Verdera","year":"2021","unstructured":"Costa-Verdera, H. et al. Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates. Nat. Commun. 12, 6393 (2021).","journal-title":"Nat. Commun."},{"key":"816_CR54","doi-asserted-by":"publisher","first-page":"5358272","DOI":"10.1155\/2016\/5358272","volume":"2016","author":"R Jefferis","year":"2016","unstructured":"Jefferis, R. Posttranslational Modifications and the Immunogenicity of Biotherapeutics. J. Immunol. Res. 2016, 5358272 (2016).","journal-title":"J. Immunol. Res."},{"key":"816_CR55","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.omtm.2022.08.001","volume":"26","author":"P Lam","year":"2022","unstructured":"Lam, P. et al. Therapeutic efficacy of rscAAVrh74.miniCMV.LIPA gene therapy in a mouse model of lysosomal acid lipase deficiency. Mol. Ther. - Methods Clin. Dev. 26, 413\u2013426 (2022).","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"816_CR56","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ymthe.2017.02.013","volume":"25","author":"ER Pozsgai","year":"2017","unstructured":"Pozsgai, E. R., Griffin, D. A., Heller, K. N., Mendell, J. R. & Rodino-Klapac, L. R. Systemic AAV-Mediated \u03b2-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice. Mol. Ther. 25, 855\u2013869 (2017).","journal-title":"Mol. Ther."},{"key":"816_CR57","doi-asserted-by":"crossref","unstructured":"Shoti, J. et al. Development of capsid- and genome-modified optimized AAVrh74 vectors for muscle gene therapy. Mol. Ther. - Methods Clin. Dev. 31, 101147 (2023).","DOI":"10.1016\/j.omtm.2023.101147"},{"key":"816_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/acn3.172","volume":"2","author":"PC Sondergaard","year":"2015","unstructured":"Sondergaard, P. C. et al. AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models. Ann. Clin. Transl. Neurol. 2, 256\u2013270 (2015).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"816_CR59","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1182\/blood-2010-10-314518","volume":"117","author":"AT Martino","year":"2011","unstructured":"Martino, A. T. et al. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver. Blood 117, 6459\u20136468 (2011).","journal-title":"Blood"},{"key":"816_CR60","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/mt.2011.280","volume":"20","author":"T Wu","year":"2012","unstructured":"Wu, T. et al. Self-complementary AAVs Induce More Potent Transgene Product-specific Immune Responses Compared to a Single-stranded Genome. Mol. Ther. 20, 572\u2013579 (2012).","journal-title":"Mol. Ther."},{"key":"816_CR61","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1172\/JCI37607","volume":"119","author":"J Zhu","year":"2009","unstructured":"Zhu, J., Huang, X. & Yang, Y. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J. Clin. Investig. 119, 2388\u20132398 (2009).","journal-title":"J. Clin. Investig."},{"key":"816_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/jgm.516","volume":"6","author":"AR Brooks","year":"2004","unstructured":"Brooks, A. R. et al. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J. Gene Med. 6, 395\u2013404 (2004).","journal-title":"J. Gene Med."},{"key":"816_CR63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1515\/bchm3.1996.377.3.195","volume":"377","author":"S Pr\u00f6sch","year":"1996","unstructured":"Pr\u00f6sch, S. et al. Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro. Biol. Chem. Hoppe. Seyler 377, 195\u2013201 (1996).","journal-title":"Biol. Chem. Hoppe. Seyler"},{"key":"816_CR64","doi-asserted-by":"crossref","unstructured":"High-dose AAV gene therapy deaths. Nat. Biotechnol. 38, 910 (2020).","DOI":"10.1038\/s41587-020-0642-9"},{"key":"816_CR65","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/jcm9082596","volume":"9","author":"KM Stepien","year":"2020","unstructured":"Stepien, K. M. et al. Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review. J. Clin. Med. 9, 2596 (2020).","journal-title":"J. Clin. Med."},{"key":"816_CR66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.omtm.2019.05.014","volume":"14","author":"A Kruzik","year":"2019","unstructured":"Kruzik, A. et al. Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors. Mol. Ther. Methods Clin. Dev. 14, 126\u2013133 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"816_CR67","doi-asserted-by":"crossref","unstructured":"Xicluna, R. et al. Prevalence Study of Cellular Capsid-Specific Immune Responses to AAV2, 4, 5, 8, 9, and rh10 in Healthy Donors. Hum. Gene Ther. 35, 355\u2013364 (2024).","DOI":"10.1089\/hum.2023.225"},{"key":"816_CR68","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-020-0911-7","volume":"26","author":"C Leborgne","year":"2020","unstructured":"Leborgne, C. et al. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. Nat. Med. 26, 1096\u20131101 (2020).","journal-title":"Nat. Med."},{"key":"816_CR69","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature12875","volume":"506","author":"L Lisowski","year":"2014","unstructured":"Lisowski, L. et al. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature 506, 382\u2013386 (2014).","journal-title":"Nature"},{"key":"816_CR70","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/mt.2016.61","volume":"24","author":"K Vercauteren","year":"2016","unstructured":"Vercauteren, K. et al. Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid. Mol. Ther. 24, 1042\u20131049 (2016).","journal-title":"Mol. Ther."},{"key":"816_CR71","doi-asserted-by":"publisher","first-page":"eaam6375","DOI":"10.1126\/scitranslmed.aam6375","volume":"9","author":"F Puzzo","year":"2017","unstructured":"Puzzo, F. et al. Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid \u03b1-glucosidase. Sci. Transl. Med. 9, eaam6375 (2017).","journal-title":"Sci. Transl. Med."},{"key":"816_CR72","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/mt.2008.72","volume":"16","author":"SC Cunningham","year":"2008","unstructured":"Cunningham, S. C., Dane, A. P., Spinoulas, A. & Alexander, I. E. Gene Delivery to the Juvenile Mouse Liver Using AAV2\/8 Vectors. Mol. Ther. J. Am. Soc. Gene Ther. 16, 1081\u20131088 (2008).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"816_CR73","doi-asserted-by":"publisher","first-page":"EVIDoa2200052","DOI":"10.1056\/EVIDoa2200052","volume":"1","author":"N Brunetti-Pierri","year":"2022","unstructured":"Brunetti-Pierri, N. et al. Liver-Directed Adeno-Associated Virus-Mediated Gene Therapy for Mucopolysaccharidosis Type VI. NEJM Evid 1, EVIDoa2200052 (2022).","journal-title":"NEJM Evid"},{"key":"816_CR74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1056\/NEJMoa2313398","volume":"390","author":"SK Eskandari","year":"2024","unstructured":"Eskandari, S. K. et al. High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman\u2019s Disease. N. Engl. J. Med. 390, 623\u2013629 (2024).","journal-title":"N. Engl. J. Med."},{"key":"816_CR75","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1182\/blood-2018-99-118334","volume":"132","author":"AC Nathwani","year":"2018","unstructured":"Nathwani, A. C. et al. Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing \u201cEmpty Viral Particles\u201d on Safety and Efficacy of Gene Transfer. Blood 132, 491 (2018).","journal-title":"Blood"},{"key":"816_CR76","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood.2021014735","volume":"140","author":"P Batty","year":"2022","unstructured":"Batty, P. et al. Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A. Blood 140, 2672\u20132683 (2022).","journal-title":"Blood"},{"key":"816_CR77","doi-asserted-by":"crossref","unstructured":"Greig, J. A. et al. Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration. Nat. Biotechnol. 42, 1\u201311 (2023).","DOI":"10.1038\/s41587-023-01974-7"},{"key":"816_CR78","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature13864","volume":"517","author":"A Barzel","year":"2015","unstructured":"Barzel, A. et al. Promoterless gene targeting without nucleases ameliorates haemophilia B in mice. Nature 517, 360\u2013364 (2015).","journal-title":"Nature"},{"key":"816_CR79","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2014-12-615492","volume":"126","author":"R Sharma","year":"2015","unstructured":"Sharma, R. et al. In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126, 1777\u20131784 (2015).","journal-title":"Blood"},{"key":"816_CR80","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128863","volume":"4","author":"A De Caneva","year":"2019","unstructured":"De Caneva, A. et al. Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases. JCI Insight 4, e128863 (2019).","journal-title":"JCI Insight"},{"key":"816_CR81","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.xcrm.2024.101619","volume":"5","author":"F Esposito","year":"2024","unstructured":"Esposito, F. et al. Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases. Cell Rep. Med. 5, 101619 (2024).","journal-title":"Cell Rep. Med."},{"key":"816_CR82","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1016\/j.ymthe.2021.03.018","volume":"29","author":"S Pagant","year":"2021","unstructured":"Pagant, S. et al. ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic \u03b1-Gal A activity and effective substrate reduction in Fabry mice. Mol. Ther. 29, 3230\u20133242 (2021).","journal-title":"Mol. Ther."},{"key":"816_CR83","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.15252\/emmm.201707601","volume":"9","author":"F Porro","year":"2017","unstructured":"Porro, F. et al. Promoterless gene targeting without nucleases rescues lethality of a Crigler\u2010Najjar syndrome mouse model. EMBO Mol. Med. 9, 1346\u20131355 (2017).","journal-title":"EMBO Mol. Med."},{"key":"816_CR84","doi-asserted-by":"publisher","first-page":"101103","DOI":"10.1016\/j.omtm.2023.08.022","volume":"31","author":"M Lisjak","year":"2023","unstructured":"Lisjak, M. et al. Lethality rescue and long-term amelioration of a citrullinemia type I mouse model by neonatal gene-targeting combined to SaCRISPR-Cas9. Mol. Ther. Methods Clin. Dev. 31, 101103 (2023).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"816_CR85","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","volume":"399","author":"F Fumagalli","year":"2022","unstructured":"Fumagalli, F. et al. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access. The Lancet 399, 372\u2013383 (2022).","journal-title":"The Lancet"},{"key":"816_CR86","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","volume":"385","author":"B Gentner","year":"2021","unstructured":"Gentner, B. et al. Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome. N. Engl. J. Med. 385, 1929\u20131940 (2021).","journal-title":"N. Engl. J. Med."},{"key":"816_CR87","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler, F. et al. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy. N. Engl. J. Med. 377, 1630\u20131638 (2017).","journal-title":"N. Engl. J. Med."},{"key":"816_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi, A. et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341, 1233158 (2013).","journal-title":"Science"},{"key":"816_CR89","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1440-1827.1999.00862.x","volume":"49","author":"K Kuriwaki","year":"1999","unstructured":"Kuriwaki, K. & Yoshida, H. Morphological characteristics of lipid accumulation in liver-constituting cells of acid lipase deficiency rats (Wolman\u2019s disease model rats). Pathol. Int. 49, 291\u2013297 (1999).","journal-title":"Pathol. Int."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00816-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00816-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00816-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:08:11Z","timestamp":1744376891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00816-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["816"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00816-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4354172\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2024.04.26.591270","asserted-by":"object"}]},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}